NPM1 and ovarian serous adenocarcinoma: In addition, in high-grade ovarian serous cancer [30], a poorer patient outcome was associated with a significant overexpression of nuclear NPM1 and in transformed ovarian cancer cells [31], elevated levels of NPM1 were reported.